Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects

NCT07421739 is registered in ClinicalTrials.gov with Aura Biosciences as lead sponsor.

NCT NCT07421739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07421739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects
Lead sponsor
Aura Biosciences
Phase
Observational
Overall status
Recruiting
Start date
November 12, 2025
Completion date
August 15, 2028
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

choroidal melanoma, indeterminate lesions, ocular melanoma, uveal melanoma